Skip to main content

Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients

Annals of Hematology volume 94, pages 481–489 (2015)Cite this article

Abstract

To gain insight into the natural history of cytomegalovirus (CMV) infection following unrelated cord blood transplantation (UCBT) in seropositive patients, we analyzed the data of 349 seropositive patients who received UCBT in Korea between 2000 and 2011. CMV reactivation occurred in 49 % (171/349) of the CMV-seropositive transplant recipients at a median of 31 days post UCBT. One hundred sixty-four out of 171 patients (96 %) received preemptive therapy. The median duration of CMV reactivation was 29 days. In multivariate analysis, weight >22 kg, use of total body irradiation, use of pre-transplant antithymocyte globulin, graft-versus-host disease (GVHD) prophylaxis with mycophenolate mofetil, and presence of grade II–IV acute GVHD were independent predictors of CMV reactivation. CMV reactivation did not impact transplantation-related mortality (TRM), leukemia relapse, or survival. CMV disease was diagnosed in 62 patients (17.8 %) at a median 55 days after UCBT. Longer duration of CMV reactivation was the only risk factor for progression to CMV disease (p = 0.01). CMV disease resulted in higher TRM (56.0 vs. 31.4 %, p < 0.01) and lower survival (36.1 vs. 55.1 %, p = 0.02).

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, Dobrila L, Rubinstein P, Stevens CE (2006) Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening. Blood 108:4275–4282

    CAS  PubMed  Article  Google Scholar 

  2. Beck JC, Wagner JE, DeFor TE, Brunstein CG, Schleiss MR, Young JA, Weisdorf DH, Cooley S, Miller JS, Verneris MR (2010) Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant 16:215–222

    PubMed Central  PubMed  Article  Google Scholar 

  3. D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M (1998) Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 83:197–203

    PubMed  Google Scholar 

  4. Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I, Bryan SG, Kaur I, Martin S, Wieder ED, Worth L, Cooper LJ, Petropoulos D, Molldrem JJ, Champlin RE, Shpall EJ (2007) Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 110:4543–4551

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  5. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9:543–558

    PubMed  Article  Google Scholar 

  6. Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, Lowenberg B, Cornelissen JJ (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 95:2240–2245

    CAS  PubMed  Google Scholar 

  7. Ljungman P, Hakki M, Boeckh M (2010) Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin N Am 24:319–337

    Article  Google Scholar 

  8. Walker CM, van Burik JA, De For TE, Weisdorf DJ (2007) Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 13:1106–1115

    PubMed  Article  Google Scholar 

  9. George B, Kerridge I, Gilroy N, Huang G, Hertzberg M, Gottlieb D, Bradstock K (2010) Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. Bone Marrow Transplant 45:849–855

    CAS  PubMed  Article  Google Scholar 

  10. Yoo KH, Lee SH, Sung KW, Koo HH, Chung NG, Cho B, Kim HK, Kang HJ, Shin HY, Ahn HS, Baek HJ, Han DK, Kook H, Hwang TJ, Kim SY, Lee YH, Hah JO, Im HJ, Seo JJ, Park SK, Jung HJ, Park JE, Lim YJ, Park SS, Lim YT, Yoo ES, Ryu KH, Park HJ, Park BK (2011) Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol 86:12–17

    PubMed  Article  Google Scholar 

  11. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34:1094–1097

    PubMed  Article  Google Scholar 

  12. Frangoul H, Wang L, Harrell FE Jr, Ho R, Domm J (2009) Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 15:1485–1488

    CAS  Article  Google Scholar 

  13. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 15:1628–1633

    PubMed Central  PubMed  Article  Google Scholar 

  14. Patel KJ, Rice RD, Hawke R, Abboud M, Heller G, Scaradavou A, Young JW, Barker JN (2010) Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. Biol Blood Marrow Transplant 16:435–440

    PubMed Central  PubMed  Article  Google Scholar 

  15. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825–828

    CAS  PubMed  Google Scholar 

  16. Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP, Fero ML, Warren EH, Lee SJ, Appelbaum FR, Martin PJ, Flowers ME (2009) Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 114:702–708

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S, Kasahara S, Iseki T, Yamaguchi T, Tojo A, Asano S (2008) Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. Eur J Haematol 80:251–257

    PubMed  Article  Google Scholar 

  18. Mikulska M, Raiola AM, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T, Frassoni F, Tedone E, Galano B, Bacigalupo A, Viscoli C (2012) CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. Biol Blood Marrow Transplant 18:92–99

    PubMed  Article  Google Scholar 

  19. Buyck HC, Prentice HG, Griffiths PD, Emery VC (2010) The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients. Bone Marrow Transplant 45:1212–1219

    CAS  PubMed  Article  Google Scholar 

  20. Pinana JL, Martino R, Barba P, Margall N, Roig MC, Valcarcel D, Sierra J, Rabella N (2010) Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience. Bone Marrow Transplant 45:534–542

    CAS  PubMed  Article  Google Scholar 

  21. Barron MA, Gao D, Springer KL, Patterson JA, Brunvand MW, McSweeney PA, Zeng C, Baron AE, Weinberg A (2009) Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin Infect Dis 49:1777–1783

    CAS  PubMed  Article  Google Scholar 

  22. Yi ES, Kim YJ (2012) Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients. Yonsei Med J 53:393–400

    PubMed Central  PubMed  Article  Google Scholar 

  23. Montesinos P, Sanz J, Cantero S, Lorenzo I, Martin G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martinez J, Jarque I, Salavert M, Cordoba J, Gomez L, Weiss S, Moscardo F, de la Rubia J, Larrea L, Sanz MA, Sanz GF (2009) Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol Blood Marrow Transplant 15:730–740

    CAS  PubMed  Article  Google Scholar 

  24. Al-Hajjar S, Al Seraihi A, Al Muhsen S, Ayas M, Al Jumaah S, Al Jefri A, Shoukri M, El Solh H (2011) Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes. Hematol/Oncol Stem Cell Ther 4:67–72

    Article  Google Scholar 

  25. Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV (2002) Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 100:3690–3697

    CAS  PubMed  Article  Google Scholar 

  26. Matsumura T, Narimatsu H, Kami M, Yuji K, Kusumi E, Hori A, Murashige N, Tanaka Y, Masuoka K, Wake A, Miyakoshi S, Kanda Y, Taniguchi S (2007) Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biol Blood Marrow Transplant 13:577–583

    PubMed  Article  Google Scholar 

  27. Kullberg-Lindh C, Mellgren K, Friman V, Fasth A, Ascher H, Nilsson S, Lindh M (2011) Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors. Transpl Infect Dis 13:122–130

    CAS  PubMed  Article  Google Scholar 

  28. Hambach L, Stadler M, Dammann E, Ganser A, Hertenstein B (2002) Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation. Bone Marrow Transplant 29:903–906

    CAS  PubMed  Article  Google Scholar 

  29. Lipsky JJ (1996) Mycophenolate mofetil. Lancet 348:1357–1359

    CAS  PubMed  Article  Google Scholar 

  30. Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T (1996) Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transpl Immunol 4:64–67

    CAS  PubMed  Article  Google Scholar 

  31. Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C (2011) Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood 118:5689–5696

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  32. Bacigalupo A, Boyd A, Slipper J, Curtis J, Clissold S (2012) Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. Expert Rev Anti-Infect Ther 10:1249–1264

    CAS  PubMed  Article  Google Scholar 

  33. Shereck EB, Cooney E, van de Ven C, Della-Lotta P, Cairo MS (2007) A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatr Blood Cancer 49:306–312

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant of Kyowa Hakko Kirin Korea Co., Ltd., 2011.

Conflict of interest

The authors declare no conflicts of interest.

Authors’ contributions

M. Park designed the study, performed the analysis, and wrote the paper; Y.H. Lee designed the study, performed the research, and reviewed the manuscript; S.H. Lee, K.H. Yoo, K.W. Sung, H.H. Koo, H.J. Kang, K.D. Park, H.Y. Shin, H.S. Ahn, N.G. Chung, B. Cho, H.K. Kim, K.N. Koh, H.J. Im, J.J. Seo, H.J. Baek, H. Kook, T.J. Hwang, J.M. Lee, J.O. Hah, Y.J. Lim, J.E. Park, C.J. Lyu, Y.T. Lim, S.Y. Chong, and D. Oh contributed to the analysis of data.

Participating centers

This study was conducted at the following institutions: College of Medicine, Chungbuk National University, Cheongju; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Hanyang University Medical Center, Hanyang University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul; Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul; Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul; Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju; Yeungnam University College of Medicine, Daegu; Chungnam National University College of Medicine, Daejon; Ajou University School of Medicine, Suwon; CHA Bundang Medical Center, CHA University, Seongnam; Mokdong Hospital, Ehwa women’s University College of Medicine, Seoul; Yonsei University College of Medicine, Seoul; Gyeongsang National University School of Medicine, Jinju; Pusan National University, School of Medicine, Pusan; National Cancer Center, Goyang; Konkuk University College of Medicine, Seoul; Gachon University Gil Hospital, Gachon University School of Medicine, Incheon; Daegu Fatima Hospital, Daegu, Korea.

Author information

Affiliations

  1. Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju, South Korea

    Meerim Park

  2. Department of Pediatrics, Hanyang University Medical Center, College of Medicine, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, 133-792, South Korea

    Young Ho Lee

  3. Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea

    Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung & Hong Hoe Koo

  4. Department of Pediatrics, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, South Korea

    Ji Won Lee, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin & Hyo Seop Ahn

  5. Department of Pediatrics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

    Jae Wook Lee, Nack-Gyun Chung, Bin Cho & Hack-Ki Kim

  6. Department of Pediatrics, Asan Medical Center Children’s Hospital, College of Medicine, University of Ulsan, Seoul, South Korea

    Kyung-Nam Koh, Ho Joon Im & Jong Jin Seo

  7. Department of Pediatrics, Chonnam National University Hwasun Hospital, Medical School, Chonnam National University, Gwangju, South Korea

    Hee Jo Baek, Hoon Kook & Tai Ju Hwang

  8. Department of Pediatrics, College of Medicine, Yeungnam University, Daegu, South Korea

    Jae Min Lee & Jeong Ok Hah

  9. Department of Pediatrics, Chungnam National University, Daejon, South Korea

    Yeon Jung Lim

  10. Department of Pediatrics, School of Medicine, Ajou University, Suwon, South Korea

    Jun Eun Park

  11. Department of Pediatrics, College of Medicine, Yonsei University, Seoul, South Korea

    Chuhl Joo Lyu

  12. Department of Pediatrics, College of Medicine, Pusan National University, Busan, South Korea

    Young Tak Lim

  13. Division of Hematology-Oncology, Department of Internal medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea

    So Young Chong & Doyeun Oh

Authors
  1. Meerim Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young Ho Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soo Hyun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keon Hee Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ki Woong Sung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong Hoe Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ji Won Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hyoung Jin Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kyung Duk Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hee Young Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hyo Seop Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jae Wook Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Nack-Gyun Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Bin Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Hack-Ki Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Kyung-Nam Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Ho Joon Im
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jong Jin Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Hee Jo Baek
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Hoon Kook
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Tai Ju Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Jae Min Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Jeong Ok Hah
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Yeon Jung Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Jun Eun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Chuhl Joo Lyu
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Young Tak Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. So Young Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Doyeun Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Cord Blood Transplantation Working Party of the Korean Society of Hematology

Corresponding author

Correspondence to Young Ho Lee.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Park, M., Lee, Y.H., Lee, S.H. et al. Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients. Ann Hematol 94, 481–489 (2015). https://doi.org/10.1007/s00277-014-2222-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2222-x

Keywords

  • Cord blood transplantation
  • Cytomegalovirus
  • Seropositive
  • Outcome